Home Biosimilar Antibodies Proteases Thrombin antibody Befovacimab (Anti-TFPI) For research use only.
Not for use in humans.

Befovacimab (Anti-TFPI)

Synonyms: BAY 1093884

Befovacimab (anti-TFPI) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitors (TFPI) with the potential to be used in  haemophilia A/B research. MW: 143.24 kD.

Befovacimab (Anti-TFPI)

Purity & Quality Control

Choose Selective Thrombin Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Befovacimab (anti-TFPI) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitors (TFPI) with the potential to be used in  haemophilia A/B research. MW: 143.24 kD.

Product Details

CAS No. 2156634-62-5
Molecular Weight 143.24
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Befovacimab (Anti-TFPI) | Befovacimab (Anti-TFPI) supplier | purchase Befovacimab (Anti-TFPI) | Befovacimab (Anti-TFPI) cost | Befovacimab (Anti-TFPI) manufacturer | order Befovacimab (Anti-TFPI) | Befovacimab (Anti-TFPI) distributor